InsidersTradesSigma
Explore the detailed record of transactions filed by Klein Christopher, Conseiller Général. Insider active across 3 companies, notably Osmotica Pharmaceuticals plc. Aggregated, 5 disclosures have been published. The latest transaction was disclosed on 18 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
Christopher Klein is the General Counsel and Secretary at Osmotica Pharmaceuticals plc and RVL Pharmaceuticals plc. In this role, he oversees the legal and regulatory affairs of the companies. His expertise in pharmaceutical law is essential for ensuring compliance and managing legal risks.